Next Article in Journal
Autologous Cellular Method Using Micrografts of Human Adipose Tissue Derived Follicle Stem Cells in Androgenic Alopecia
Next Article in Special Issue
A Dual GLP-1/GIP Receptor Agonist Does Not Antagonize Glucagon at Its Receptor but May Act as a Biased Agonist at the GLP-1 Receptor
Previous Article in Journal
Long Non-coding RNAs as Important Biomarkers in Laryngeal Cancer and Other Head and Neck Tumours
Previous Article in Special Issue
Glucagon Receptor Signaling and Glucagon Resistance

Glucagon, GLP-1 and Thermogenesis

Institute for Diabetes and Obesity, Helmholtz Diabetes Center, Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), 85764 Neuherberg, Germany
Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela-Instituto de Investigación Sanitaria, 15782 Santiago de Compostela, Spain
Centro de Investigación Biomédica en Red, Fisiopatología de la Obesidad y Nutrición (CIBERobn), 15706 Santiago de Compostela, Spain
Department of Physiology, Pharmacy School, Complutense University of Madrid, 28040 Madrid, Spain
Authors to whom correspondence should be addressed.
Int. J. Mol. Sci. 2019, 20(14), 3445;
Received: 20 June 2019 / Revised: 9 July 2019 / Accepted: 10 July 2019 / Published: 13 July 2019
(This article belongs to the Special Issue The Biology and Pharmacology of Glucagon)
Brown adipose tissue (BAT) thermogenesis is a conserved mechanism to maintain body temperature in mammals. However, since BAT contribution to energy expenditure can represent a relevant modulator of metabolic homeostasis, many studies have focused on the nervous system and endocrine factors that control the activity of this tissue. There is long-established evidence that the counter-regulatory hormone glucagon negatively influences energy balance, enhances satiety, and increases energy expenditure. Despite compelling evidence showing that glucagon has direct action on BAT thermogenesis, recent findings are questioning this conventional attribute of glucagon action. Glucagon like peptide-1 (GLP-1) is an incretin secreted by the intestinal tract which strongly decreases feeding, and, furthermore, improves metabolic parameters associated with obesity and diabetes. Therefore, GLP-1 receptors (GLP-1-R) have emerged as a promising target in the treatment of metabolic disorders. In this short review, we will summarize the latest evidence in this regard, as well as the current therapeutic glucagon- and GLP-1-based approaches to treating obesity. View Full-Text
Keywords: glucagon; GLP1; thermogenesis; brown adipose tissue; browning; hypothalamic control of energy balance glucagon; GLP1; thermogenesis; brown adipose tissue; browning; hypothalamic control of energy balance
Show Figures

Figure 1

MDPI and ACS Style

González-García, I.; Milbank, E.; Diéguez, C.; López, M.; Contreras, C. Glucagon, GLP-1 and Thermogenesis. Int. J. Mol. Sci. 2019, 20, 3445.

AMA Style

González-García I, Milbank E, Diéguez C, López M, Contreras C. Glucagon, GLP-1 and Thermogenesis. International Journal of Molecular Sciences. 2019; 20(14):3445.

Chicago/Turabian Style

González-García, Ismael, Edward Milbank, Carlos Diéguez, Miguel López, and Cristina Contreras. 2019. "Glucagon, GLP-1 and Thermogenesis" International Journal of Molecular Sciences 20, no. 14: 3445.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop